Cronos Group Inc. (CRON)

Market Cap	930.68M
Revenue (ttm)	94.81M
Net Income (ttm)	-223.49M
Shares Out	379.09M
EPS (ttm)	-0.60
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	481,869
Open	2.50
Previous Close	2.52
Day's Range	2.46 - 2.54
52-Week Range	2.39 - 4.31
Beta	1.37
Analysts	Buy
Price Target	4.35 (+76.83%)
Earnings Date	Feb 27, 2023

About CRON

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Mr. Michael Ryan Gorenstein J.D.
• Employees: 626
• Stock Exchange: NASDAQ
• Ticker Symbol: CRON

Financial Performance

In 2021, Cronos Group's revenue was $74.44 million, an increase of 59.32% compared to the previous year's $46.72 million. Losses were -$396.11 million, 441.6% more than in 2020.

Analyst Forecast

According to 18 analysts, the average rating for CRON stock is "Buy." The 12-month stock price forecast is $4.35, which is an increase of 76.83% from the latest price.

Price Target

$4.35

(76.83% upside)

Analyst Consensus: Buy